Soluble complement receptor one (sCR1) inhibits the development and progression of rat collagen-induced arthritis

Clinical and Experimental Immunology

Volumn 119, Issue 1, 2000, Pages 210-216

  Goodfellow, R M ^a   Williams, A S ^a   Levin, J L ^a,c   Williams, B D ^a   Morgan, B P ^a,b  

^a Department of Rheumatology ^*  (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c AVANT Immunotherapeutics Inc   (United States)

Author keywords

Animal models; Complement inhibition; SCR1

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; COMPLEMENT INHIBITION; IMMUNOPATHOGENESIS; INFLAMMATION; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS; ARTHRITIS, RHEUMATOID; COBRA VENOMS; COLLAGEN; COMPLEMENT INACTIVATOR PROTEINS; DISEASE MODELS, ANIMAL; MALE; RATS; RATS, INBRED LEW; RECEPTORS, COMPLEMENT 3B; SOLUBILITY; TIME FACTORS;

EID: 0033956212     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01129.x     Document Type: Article

References (32)

1. 1 Morgan BP. The biological effects of complement activation. In: Complement, clinical aspects and relevance to disease. London: Academic Press, 1990:130-40.
2. 2 Morgan BP, Daniels RH, Williams BD. Measurement of terminal complement complexes in rheumatoid arthritis. Clin Exp Immunol 1988; 73:473-8.
3. 3 Sanders ME, Kopicky JA, Wigley FM, Shin ML, Frank MM, Joiner KA. Membrane attack complex ot complement in rheumatoid synovial tissue demonstrated by immunofluorescent microscopy. J Rheumatol 1986; 13:1028-34.
4. 4 Kemp PA, Spragg JH, Brown JC, Morgan BP, Gunn CA, Taylor PW. Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen specific monoclonal antibodies. J Clin Lab Immunol 1992; 37:147-62.
5. 5 Morgan K, Clague RB, Shaw MJ, Firth SA, Twose TM, Lennox Holt PJ. Native type 2 collagen induced arthritis in the rat. The effect of complement depletion by cobra venom factor. Arthritis Rheum 1981; 24:1356-62.
6. 6 Kerwar SS, Bauman N, Cronsky AL, Sloboda AE. Studies on type II collagen induced polyarthritis in rats effect of complement depletion. J Immunopharmacol 1982; 3:323-37.
7. 7 Schwab JH, Allen JB, Anderle SK, Dallorf F, Eisenberg R, Cromartie WJ. Relationship of complement to experimental arthritis induced in rats by streptococcal cell walls. Immunology 1982; 46:83-7.
8. 8 Goodfellow RM, Williams AS, Levin JL, Williams BD, Morgan BP. Local therapy with soluble complement receptor one (sCR 1) suppresses inflammation in rat mono-articular arthritis. Clin Exp Immunol 1997; 110:45-52.
9. 9 Weisman MF, Barlow T, Leppo MK et al. Soluble human complement receptor type 1. In vivo inhibitor of complement suppressing post ischaemic myocardial inflammation and necrosis. Science 1990; 249:146-51.
10. 10 Piddlesden SJ, Storch MK, Hobbs M, Freeman AM, Lassmann H, Morgan BP. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody mediated demyelinating experimental allergic encephalomyelitis (ADEAE). J Immunol 1994; 152:5477-84.
11. 11 Pratt JR, Hibbs MJ, Laver AJ, Smith RAG, Sacks SH. Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat. Am J Pathol 1996; 149:2055-66.
12. 12 Couser WG, Johnson RJ, Young BA, Yeh CG, Toth CA, Rudolph AR. The effects of soluble recombinant complement receptor 1 on complement mediated experimental glomerulonephritis. J Am Soc Nephrol 1995; 5:1888-94.
13. 13 Miller EJ. Structural studies on cartilage collagen employing limited cleavage and solubilisation by pepsin. Biochemistry 1972; 11:4903-9.
14. 14 Stuart JM, Cremer MA, Townes AS, Kang AH. Type II collagen-induced arthritis in rats: passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med 1982; 155:1-16.
15. 15 Lachmann PJ, Hobart MJ. Complement technology. In: Weir DM, ed. Handbook of experimental immunology, 3rd edn, Vol. I, Chapter 5A. Oxford: Blackwell Scientific Publications, 1978.
16. 16 Whaley K. Measurement of complement. In: Whaley K, ed. Methods in complement for clinical immunologists. Edinburgh: Churchill-Livingstone, 1985:77-139.
17. 17 Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977; 146: 857-67.
18. 18 Caulfield JP, Hein A, Dynesius-Trentham R, Trentham DE. Morphologic demonstration of two stages in the development of type II collagen-induced arthritis. Lab Invest 1982; 46:321-43.
19. 19 Terato K, Hashida R, Miyamoto K et al. Histological, immunological and biochemical studies on type II collagen-induced arthritis in rats. Biochem Res 1982; 3:495-505.
20. 20 Steffen C, Timpl R. Antigenicity of collagen and its application in the serological investigation of rheumatoid arthritis sera. Int Arch Allergy Appl Immunol 1963; 22:333-40.
21. 21 Andriopoulos NA, Mestecky J, Miller GJ, Bradley EL. Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum 1976; 19:613-7.
22. 22 Trentham DE, Townes AS, Kang AH, David JR. Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest 1978; 61:89-96.
23. 23 Morgan K, Clague RB, Shaw MJ, Holt PJL. Native type II collagen-induced arthritis in the rat I. Incidence and humoral response to collagen. Ann Rheum Dis 1980; 39:285-90.
24. 24 Sloboda AE, Birnbaum JE, Oronsky AL, Kerwar SS. Studies on type II collagen induced polyarthritis in rats: effect of antiinflammatory and antirheumatic drugs. Arthritis Rheum 1981; 24:616-23.
25. 25 Stuart JM, Myers LK, Townes AS, Kang AH. Effect of cyclophosphamide, hydrocortisone and levamisole on collagen-induced arthritis in rats. Arthritis Rheum 1981; 24:790-4.
26. 26 Breban M, Fournier C, Gougerot-Pocidalo M, Muffat-Joly M, Pocidalo J. Protective effects of ciprofloxacin against type II collagen induced arthritis in rats. J Rheumatol 1992; 19:216-22.
27. 27 Staines NA, Hardingham T, Smith M, Henderson B. Collagen-induced arthritis in the rat: modification of immune responses by free collagen and immune anti-collagen antiserum. Immunology 1981; 44:737-44.
28. 28 Clague RB, Morgan K, Shaw MH, Holt PLJ. Native type II collagen induced arthritis in rats. II Relationship between the humoral immune response to native type II collagen and arthritis. J Rheumatol 1980; 7:775-81.
29. 29 Griffiths MM, Eichwald EJ, Martin JH, Smith CB, DeWitt CW. Immunogenetic control of experimental type II collagen-induced arthritis I. Susceptibility and resistance among inbred strains of rats. Arthritis Rheum 1981; 24:781-9.
30. 30 Furthmayr H, Timpl R. Immunochemistry of collagens and procollagens. International review of connective tissue research, Vol. 7. New York: Academic Press, 1976:61-99.
31. 31 Knight SC, Mertin J, Stackpole A, Clarke JC. Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. Proc Natl Acad Sci USA 1983; 80:6032-5.
32. 32 Wang Y, Rollins SA, Madri JA, Malis LA. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc Natl Acad Sci USA 1995; 92:8955-9.